Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection

Journal of Medical Virology

Volumn 81, Issue 9, 2009, Pages 1531-1538

  Ji, Sun Jang ^a,b   Hyoung, Su Kim ^a   Ha, Jung Kim ^a   Woon, Geon Shin ^a   Kyung, Ho Kim ^a   Jin, Heon Lee ^a   Hak, Yang Kim ^a   Dong, Joon Kim ^a   Myung, Seok Lee ^a   Choong, Kee Park ^a   Jeong, Byung Hoon ^c   Kim, Yong Sun ^c   Myoung, Kuk Jang ^a  

^a Hallym University Medical Center   (South Korea)

^b Seoul Veterans Hospital   (South Korea)

^c Hallym University   (South Korea)

Author keywords

Concurrent hepatitis B surface antigen and antibody; Genotype C; Hepatitis B virus; Hepatocellular carcinoma

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE SEQUENCE; GENETIC ASSOCIATION; HEPATITIS B; HUMAN; INFANT; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; RISK FACTOR; SCHOOL CHILD; VIRAL GENETICS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; FEMALE; GENOTYPE; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INFANT; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SEQUENCE DELETION; YOUNG ADULT;

HEPATITIS B VIRUS;

EID: 68949163172     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21577     Document Type: Article

References (41)

1. Beasley RP. 1988. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 61:1942-1956.
2. Bläckberg J, Kidd-Ljunggren K. 2003. Mutationswithin the hepatitisB virus genome among chronic hepatitis B patients with hepatocellular carcinoma. J Med Virol 71:18-23. (Pubitemid 37121908)
3. Bruix J, Sherman M. 2005. Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 42:1208-1236.
4. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, Huang GT, Iloeje UH, REVEAL-HBV Study Group. 2006. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. J Am Med Assoc 295:65-73. (Pubitemid 43042691)
5. Chen CH, Changchien CS, Lee CM, Hung CH, Hu TH,Wang JH,Wang JC, Lu SN. 2008. Combined mutations in pre-S/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: A case-control study. J Infect Dis 198:1634-1642.
6. Chisari FV, Filippi P, Buras J, McLachlan A, Popper H, Pinkert CA, Palmiter RD, Brinster RL. 1987. Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc Natl Acad Sci USA 84:6909-6913. (Pubitemid 18025500)
7. Chisari FV, Klopchin K, Moriyama T, Pasquinelli C, Dunsford HA, Sell S, Pinkert CA, Brinster RL, Palmiter RD. 1989. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 59:1145-1156. (Pubitemid 20024625)
8. Choi MS,KimDY, LeeDH, Lee JH,Koh KC, Paik SW,Rhee JC, Yoo BC. 2007. Clinical significance of pre-S mutations in patients with genotype C hepatitis B virus infection. J ViralHepatol 14:161-168. (Pubitemid 46257181)
9. Colson P, Borentain P, Motte A, Henry M, Moal V, Botta-Fridlund D, Tamalet C, Gérolami R. 2007. Clinical and biological significance of the co-existence of HBsAg and anti-HBs antibodies in hepatitis B chronic carriers. Virology 367:30-40. (Pubitemid 47418929)
10. de Jongh FE, Janssen HL, de Man RA, Hop WC, Schalm SW, van Blankenstein M. 1992. Survival and prognostic indicators in hepatitis B surface antigen positive cirrhosis of liver. Gastroenterology 103:1630-1635.
11. Dienstag JL. 1987. Concurrent hepatitis B surface antigen and antibody and the clonal selection theory of antibody diversity. Gastroenterology 93:899-902. (Pubitemid 17156019)
12. Fan YF, Lu CC, Chang YC, Chang TT, Lin PW, Lei HY, Su IJ. 2000. Identification of a pre-S2 mutant in hepatocytes expressing a novel marginal pattern of surface antigen in advanced diseases of chronic hepatitis B virus infection. J Gastroenterol Hepatol 15:519-528.
13. Fan YF, Lu CC, ChenWC, Yao WJ, WangHC, Chang TT, Lei HY, Shiau AL, Su IJ. 2001. Prevalence and significance of hepatitis B virus (HBV) pre-S mutants in serum and liver at different replicative stages of chronic HBV infection. Hepatology 33:277-286.
14. Fang ZL, Sabin CA, Dong BQ, Wei SC, Chen QY, Fang KX, Yang JY, Huang J, Wang XY, Harrison TJ. 2008. Hepatitis B virus pre-S deletion mutations are a risk factor for hepatocellular carcinoma: A matched nested case-control study. J Gen Virol 89:2882-2890.
15. Gao ZY, Li T, Wang J, Du JM, Li YJ, Li J, Lu FM, Zhuang H. 2007. Mutations in preS genes of genotype C hepatitis B virus in patients with chronic hepatitis B and hepatocellular carcinoma. J Gastroenterol 42:761-768. (Pubitemid 47456764)
16. Gerber MA, Hadziyannis S, Vissoulis C, Schaffner F, Paronetto F, Popper H. 1974. Electron microscopy and immunoelectron microscopy of cytoplasmic hepatitis B antigen in hepatocytes. Am J Pathol 75:489-502.
17. Hagen TM, Huang S, Curnutte J, Fowler P, Martinez V, Wehr CM, Ames BN, Chisari FV. 1994. Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. Proc Natl Acad Sci USA 91:12808-12812.
18. Hayashi J, Noguchi A, Nakashima K, Morofuji M, Kashiwagi S. 1990. Frequency of concurrence of hepatitis B surface antigen and antibody in a large number of carriers in Okinawa, Japan. Gastroenterol Jpn 25:593-597.
19. Heijtink RA, van Hattum J, Schalm SW, Masurel N. 1982. Co-occurrence of HBsAg and anti-HBs: Two consecutive infections or a sign of advanced chronic liver disease? JMed Virol 10:83-90.
20. Hsieh YH, Su IJ, Wang HC, Chang WW, Lei HY, Lai MD, Chang WT, Huang W. 2004. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis 25:2023-2032. (Pubitemid 39405923)
21. Lada O, Benhamou Y, Poynard T, Thibault V. 2006. Coexistence of hepatitis B surface antigen (HBsAg) and anti-HBs antibodies in chronic hepatitis B virus carriers: Influence of "a" determinant variants. J Virol 80:2968-2975.
22. Lin CL,Kao JH. 2008.Hepatitis B viral factors and clinical outcomes of chronic hepatitis B. J Biomed Sci 15:137-145.
23. Lok AS, McMahon BJ. 2007. Chronic hepatitis B. Hepatology 45:507-539.
24. Lu HY, Zeng Z, Xu XY, Zhang NL, YuM, Gong WB. 2006. Mutations in surface and polymerase gene of chronic hepatitis B patients with coexisting HBsAg and anti-HBs. World J Gastroenterol 12:4219-4223. (Pubitemid 44376907)
25. Margeridon S, Lachaux A, Trepo C, Zoulim F, Kay A. 2005. A quasimonoclonal anti-HBs response can lead to immune escape of 'wild-type' hepatitis B virus. J Gen Virol 86:1687-1693.
26. Mun HS, Lee SA, Jee Y, Kim H, Park JH, Song BC, Yoon JH, Kim YJ, Lee HS, Hyun JW, Hwang ES, Kook YH, Kim BJ. 2008. The prevalence of hepatitisBvirus preS deletions occurring naturally in Korean patients infected chronically with genotype C. J Med Virol 80:1189-1194. (Pubitemid 351705997)
27. Naito H, Hayashi S, Abe K. 2001. Rapid and specific genotyping system for hepatitis B virus corresponding to six major genotypes by PCR using type-specific primers. J Clin Microbiol 39:362-364. (Pubitemid 32059621)
28. Poland GA, Jacobson RM. 2004. Clinical practice: Prevention of hepatitis B with the hepatitis B vaccine. N Engl J Med 351:2832-2838.
29. Shiels MT, Taswell HF, Czaja AJ, Nelson C, Swenke P. 1987. Frequency and significance of concurrent hepatitis B surface antigen and antibody in acute and chronic hepatitis B. Gastroenterology 93:675-680. (Pubitemid 17155990)
30. Song BC, Cui XJ, Kim H. 2005. Hepatitis B virus genotypes in Korea: An endemic area of hepatitis B virus infection. Intervirology 48:133-137. (Pubitemid 41201503)
31. Song BC, Cui XJ, Kim HU, Cho YK. 2006. Sequential accumulation of the basal core promoter and the precore mutations in the progression of hepatitis B virus-related chronic liver disease. Intervirology 49:266-273.
32. Swenson PD, Escobar MR, Carithers RL, Jr, Sobieski TJ III. 1983. Failure of preexisting antibody against hepatitis B surface antigen to prevent subsequent hepatitis B infection. J Clin Microbiol 18:305-309.
33. Tangkijvanich P, Anukulkarnkusol N, Suwangool P, Lertmaharit S, Hanvivatvong O, Kullavanijaya P, Poovorawan Y. 2000. Clinical characteristics and prognosis of hepatocellular carcinoma: Analysis based on serum alpha-fetoprotein levels. J Clin Gastroenterol 31:302-308.
34. Trepo CG, Robert D, Motin J, Trepo D, Sepetjian M, Prince AM. 1976. HepatitisBantigen (HBSAg) and/or antibodies (anti-HBS and anti- HBC) in fulminant hepatitis: Pathogenic and prognostic signifi- cance. Gut 17:10-13.
35. Tsang TK, Blei AT, O'Reilly DJ, Decker R. 1986. Clinical significance of concurrent hepatitis B surface antigen and antibody positivity. Dig Dis Sci 31:620-624. (Pubitemid 16064016)
36. Wang YJ, Lee SD,WuJC, Lo KJ. 1991. Acute hepatitisBviral infection in a patient with anti-HBs. J Med Virol 35:133-135.
37. Wang YM, Ng WC, Lo SK. 1999. Detection of pre-S/S gene mutants in chronic hepatitis B carriers with concurrent hepatitis B surface antibody and hepatitis B surface antigen. J Gastroenterol 34:600-606.
38. Wang HC, Huang W, Lai MD, Su IJ. 2006. Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis. Cancer Sci 97:683-688. (Pubitemid 43983778)
39. Weinberger KM, Zoulek G, Bauer T, Böhm S, Jilg W. 1999. A novel deletion mutant of hepatitis B virus surface antigen. J Med Virol 58:105-110. (Pubitemid 29226850)
40. Xu Z, Yen TS. 1996. Intracellular retention of surface protein by a hepatitis B virus mutant that releases virion particles. J Virol 70:133-140. (Pubitemid 126508778)
41. Zhang KY, Imazeki F, Fukai K, Arai M, Kanda T, Mikata R, Yokosuka O. 2007. Analysis of the complete hepatitis B virus genome in patients with genotype C chronic hepatitis and hepatocellular carcinoma. Cancer Sci 98:1921-1929. (Pubitemid 350002198)